GC
Gopalakrishna Chittajallu
About Gopalakrishna Chittajallu
Data last updated:
Gopalakrishna Chittajallu has 18 years in corporate governance. Holds Director and Additional Director roles. Currently with 5 companies, including Wallet Pharma Private Limited and Evaric Pharma Private Limited. Formerly with 6 companies, such as Cirex Pharmaceuticals Private Limited and Alcedo Pharmachem Private Limited. Engaged in General Business. Contributes to corporate operations. The 3 current companies with reported revenue have a combined latest revenue of ₹25.86 Cr; the largest is Sri Sai Ashirwaad Enterprises Private Limited at ₹18.81 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Sri Sai Ashirwaad Enterprises Private Limited U74999TG2007PTC056072 | Additional Director | 09 Oct 2025 | 2007 | ₹18.81 Cr (FY 2025) | Active |
| Wallet Pharma Private Limited U24100TG2015PTC102108 | Director | 20 Jun 2017 | 2015 | ₹4.67 Cr (FY 2025) | Active |
| Abhiru Industries Limited U24304TG2017PLC116098 | Director | 23 Mar 2017 | 2017 | ₹2.38 Cr (FY 2025) | Active |
| Actero Pharma Private Limited U24304TG2016PTC111055 | Director | 20 Jun 2017 | 2016 | – | Active |
| Anaika Industries Limited U24303TG2017PLC117168 | Director | 18 May 2017 | 2017 | – | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Cirex Pharmaceuticals Private Limited U24239TG1990PTC012119 | Director | 24 Jul 2017 | 1990 | ₹27.51 Cr (FY 2025) | Active |
| Alcedo Pharmachem Private Limited U24239TG2016PTC111056 | Director | 20 Jun 2017 | 2016 | ₹89.55 Cr (FY 2025) | Active |
 Hetero Drugs Limited U24230TG1993PLC015582 | Company Secretary | 07 Aug 2008 | 1993 | ₹3,324 Cr (FY 2025) | Active |
 Annora Pharma Private Limited U24100TG2015PTC101939 | Company Secretary | 20 Jun 2017 | 2015 | ₹1,494 Cr (FY 2025) | Active |
| Evaric Pharma Private Limited U24100TG2015PTC102128 | Director | 20 Jun 2017 | 2015 | – | Strike Off |
| Glenys Lab Private Limited U24110TG2015PTC098451 | Director | 24 Mar 2017 | 2015 | – | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Gopalakrishna Chittajallu
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Gopalakrishna Chittajallu
Gopalakrishna Chittajallu has 18 years in corporate governance. Holds Director and Additional Director roles. Currently with 5 companies, including Wallet Pharma Private Limited and Evaric Pharma Private Limited. Formerly with 6 companies, such as Cirex Pharmaceuticals Private Limited and Alcedo Pharmachem Private Limited. Engaged in General Business. Contributes to corporate operations. The 3 current companies with reported revenue have a combined latest revenue of ₹25.86 Cr; the largest is Sri Sai Ashirwaad Enterprises Private Limited at ₹18.81 Cr (FY 2025).
Gopalakrishna Chittajallu is associated with 5 companies as Director and Additional Director, including Sri Sai Ashirwaad Enterprises Private Limited (₹18.81 Cr), Wallet Pharma Private Limited (₹4.67 Cr), Abhiru Industries Limited (₹2.38 Cr).
Gopalakrishna Chittajallu has expertise in General Business.
Gopalakrishna Chittajallu has 18 years in corporate governance.
By reported revenue, the largest current company of Gopalakrishna Chittajallu is Sri Sai Ashirwaad Enterprises Private Limited, with revenue of ₹18.81 Cr (FY 2025).
The 3 current companies of Gopalakrishna Chittajallu that report revenue have a combined latest revenue of ₹25.86 Cr.
Gopalakrishna Chittajallu currently holds positions at 5 companies: Sri Sai Ashirwaad Enterprises Private Limited (₹18.81 Cr), Wallet Pharma Private Limited (₹4.67 Cr), Abhiru Industries Limited (₹2.38 Cr), Actero Pharma Private Limited, Anaika Industries Limited.